Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Tumor-Agnostic 1Genitourinary 1

Conditions

Lung Neoplasms 3

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Patient Education as Topic × Thoracic × 1 year × Clear all
NCT06225414 2026-03-30

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

University of California, Irvine

Phase NA Completed
60 enrolled
Thoracic

Lung Neoplasms

NCT06000683 2026-02-20

Empower-LCS

University of California, Irvine

Phase NA Completed
79 enrolled 20 charts
Thoracic

Lung Neoplasms

NCT05747443 2025-12-24

Larch

Kaiser Permanente

Phase NA Active not recruiting
1,837 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡